93164-43-3

Basic information

• Product Name: ethyl 4-(tosyloxy)cyclohexanecarboxylate
• Synonyms: ethyl 4-(tosyloxy)cyclohexanecarboxylate;Cyclohexanecarboxylic acid, 4-[[(4-Methylphenyl)sulfonyl]oxy]-, ethyl ester
• CAS NO: 93164-43-3
• Molecular Formula: C₁₆H₂₂O₅S
• Molecular Weight: 326
• Mol File: 93164-43-3.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ethyl 4-(tosyloxy)cyclohexanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(tosyloxy)cyclohexanecarboxylate(93164-43-3)
• EPA Substance Registry System: ethyl 4-(tosyloxy)cyclohexanecarboxylate(93164-43-3)

Safety Data

• Hazardous Substances Data: 93164-43-3(Hazardous Substances Data)

Upstream product

• 3685-26-5 cis-4-hydroxycyclohexanecarboxylic acid 
• 75877-66-6 ethyl (1s,4s)-4-hydroxycyclohexanecarboxylate 
• 98-59-9 p-toluenesulfonyl chloride 
• 3618-04-0 4-hydroxycyclohexyl carboxylic acid ethyl ester 
• 7133-31-5 4-methylcyclohexanecarboxylic acid ethyl ester 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 

Downstream Products

• 1350323-14-6 trans-4-(4-{3-[(1S)-1-(2-Chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,5-dimethyl-1H-pyrazol-1-yl)cyclohexanecarboxylic acid 
• 1350323-12-4 ethyl trans-4-(4-{3-[(1S)-1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3,5-dimethyl-1H-pyrazol-1-yl)cyclohexanecarboxylate 
• 1350323-15-7 ethyl trans-4-[3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]cyclohexanecarboxylate 
• 1350322-91-6 ethyl trans-4-(4-iodo-3-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylate 
• 1350322-93-8 ethyl trans-4-(4-iodo-5-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylate 
• 1350324-33-2 trans-4-[4-(3-{(1S)-1-[2-chloro-6-(difluoromethoxy)-3-fluorophenyl]ethyl}-1H-pyrrolo[2,3-b]pyridin-5-yl)-5-methyl-1H-pyrazol-1-yl]cyclohexanecarboxamide 
• 1350322-88-1 Trans-4-(4-{3-[(1S)-1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-5-methyl-1H-pyrazol-1-yl)-N,N-dimethylcyclohexanecarboxamide 
• 1350322-89-2 trans-4-(4-{3-[(1S)-1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-5-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylic acid 
• 1350322-90-5 ethyl trans-4-(4-{3-[(1S)-1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-5-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylate 
• 1350322-92-7 ethyl trans-4-[5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]cyclohexanecarboxylate 
• 1350323-01-1 trans-4-(4-{3-[(1S)-1-(2-Chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylic acid 
• 1350323-02-2 ethyl trans-4-(4-{3-[(1S)-1-(2-chloro-3-fluoro-6-methoxyphenyl)ethyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-3-methyl-1H-pyrazol-1-yl)cyclohexanecarboxylate 
• 1350323-04-4 ethyl trans-4-[3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]cyclohexanecarboxylate 

Relevant articles and documents

Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors

The ability to restrict low molecular weight compounds to the gastrointestinal (GI) tract may enable an enhanced therapeutic index for molecular targets known to be associated with systemic toxicity. Using a triazolopyrazine CSF1R inhibitor scaffold, a br

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.